| Classic tumor markers in gastric cancer. Current standards and limitations C Căinap, V Nagy, A Gherman, S Cetean, I Laszlo, AM Constantin, ... Clujul medical 88 (2), 111, 2015 | 65 | 2015 |
| The importance of the granulocyte-colony stimulating factor in oncology S Cetean, C Căinap, AM Constantin, S Căinap, A Gherman, L Oprean, ... Clujul medical 88 (4), 468, 2015 | 50 | 2015 |
| Current and new predictors for treatment response in metastatic colorectal cancer. The role of circulating miRNAs as biomarkers A Gherman, L Balacescu, S Gheorghe-Cetean, C Vlad, O Balacescu, ... International journal of molecular sciences 21 (6), 2089, 2020 | 20 | 2020 |
| Hypersensitivity reactions to platinum derivatives: findings of new predictive markers S Cetean, T Ciuleanu, DC Leucuta, C Cainap, AM Constantin, I Cazacu, ... J. BUON 20 (6), 1617, 2015 | 16 | 2015 |
| Platinum derivatives: a multidisciplinary approach S Gheorghe-Cetean, C Cainap, L Oprean, A Hangan, P Virag, ... J BUON 22 (3), 568-577, 2017 | 13 | 2017 |
| Molecular targeted treatment of metastatic colorectal cancer: The cardiovascular adverse effects of Bevacizumab and Cetuximab A Gherman, C Căinap, AM Constantin, S Cetean, SS Căinap Clujul Medical 90 (4), 377, 2017 | 8 | 2017 |
| Results of third-generation epirubicin/cisplatin/xeloda adjuvant chemotherapy in patients with radically resected gastric cancer C Cainap, V Nagy, A Seicean, A Gherman, I Laszlo, C Lisencu, AH Nadim, ... J. BU ON 21, 349-359, 2016 | 7 | 2016 |
| Efficacy of cetuximab/panitumumab after previous bevacizumab in metastatic colorectal cancer A Gherman, C Cainap, ȘC Vesa, AD Havasi, A Trifon, SS Cainap, ... Farmacia 68 (4), 656-664, 2020 | 6 | 2020 |
| Continuous intravenous administration of granulocyte-colony-stimulating factors—a breakthrough in the treatment of cancer patients with febrile neutropenia C Căinap, S Cetean-Gheorghe, LA Pop, DC Leucuta, D Piciu, A Mester, ... Medicina 57 (7), 675, 2021 | 5 | 2021 |
| Baseline expression of exosomal miR-92a-3p and miR-221-3p could predict the response to first-line chemotherapy and survival in metastatic colorectal cancer A Gherman, L Balacescu, C Popa, C Cainap, C Vlad, SS Cainap, ... International Journal of Molecular Sciences 24 (13), 10622, 2023 | 4 | 2023 |
| Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis C Cainap, RA Ungur, OV Bochis, P Achimas, C Vlad, A Havasi, A Vidrean, ... Plos one 16 (4), e0248922, 2021 | 3 | 2021 |
| The role of sentinel lymph node analysis in patients with colorectal cancer undergoing surgery B Micu, C Micu, A Gherman, M Sava, TR Pop, N Constantea Human and Veterinary Medicine 7 (2), 114-117, 2015 | 1 | 2015 |
| Unselective Measurement of Tumor-to-Stroma Proportion in Colon Cancer at the Invasion Front—An Elusive Prognostic Factor: Original Patient Data and Review of the Literature Z Fekete, P Ignat, AC Resiga, N Todor, AS Muntean, L Resiga, S Curcean, ... Diagnostics 14 (8), 836, 2024 | | 2024 |
| Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer A Gherman, D Bolundut, R Ecea, L Balacescu, S Curcean, C Dina, ... Medicina 60 (3), 397, 2024 | | 2024 |
| Predictive biomarkers of febrile neutropenia resolution in cancer patients. Are platelets the new rising stars of the immune system? S Gheorghe-Cetean, DC Leucușa, P Achimaț-Cadariu, C Căinap, ... Human and Veterinary Medicine 15 (1), 1-6, 2023 | | 2023 |
| The role of hematological inflammation markers in predicting survival in metastatic colorectal cancer A Gherman, C Căinap, AD Havași, ȘC Vesa, S Gheorghe-Cetean, ... Human and Veterinary Medicine 12 (3), 101-107, 2020 | | 2020 |
| A breakthrough in treatment of cancer patients with grade 4/profound febrile neutropenia. CI Cainap, SS Cainap, S Cetean-Gheorghe, DC Leucuta, OV Bochis, ... Journal of Clinical Oncology 37 (15_suppl), e14513-e14513, 2019 | | 2019 |
